Continuous Glucose Monitoring: Complete Care Management Solution for Diabetes
Thursday, February 28, 2019
7:30 AM - 8:30 AM
This education program is designed for the healthcare professional involved in the care and case management of persons with Diabetes Mellitus. This program focuses on current clinical studies supporting the use of CGM for all patients on Intensive Insulin Therapy (IIT), highlighting how CGM can improve glycemic control and overall quality of life for people with diabetes. The category of CGM is rapidly changing, advances in CGM accuracy and improved usability have changed the way patients and clinicians use CGM to manage diabetes. This program will cover the latest developments in CGM technology including its use for diabetes treatment decisions and the ability to regulate insulin delivery from a pump. Learn how the use of retrospective data and remote monitoring can improve case management and outcomes. Cost modeling scenarios will illustrate the savings potential associated with CGM and show how diabetes management cost can be reduced with CGM use.
- Demonstrate how CGM helps patients optimize diabetes treatment plans leading to improved clinical outcomes
- Review FDA approved CGM devices currently available in the US, features of each system and product comparisons
- Identify clinical studies that demonstrate the benefit of CGM for all patients on IIT
- Demonstrate how retrospective analysis and remote monitoring improve case management and outcomes
- Review the potential diabetes management savings associated with CGM using cost modeling scenarios
Renee Taylor, MS, RD, BC-ADM, CDE
Medical Science Liaison
Nicholas B. Argento, MD
Senior Clinical Endocrinologist
Maryland Endocrine and Diabetes Center
About the Speakers:
Renee Taylor is a Certified Diabetes Educator and Registered Dietitian with Board Certification in Advanced Diabetes Management. She has over two decades’ experience in diabetes care and has spent the last 12 years specializing in the field of continuous glucose monitoring. Currently, Renee serves as a Medical Science Liaison for Dexcom®. Renee holds a Master’s of Science degree in Nutrition with a minor in Biochemistry and is a national speaker on diabetes and continuous glucose monitoring.
Dr. Argento is a senior clinical endocrinologist at the Maryland Endocrine and Diabetes Center in Columbia, Maryland, where he serves as the Diabetes Technology Director. 90% of his practice involves treating people with diabetes, about half of whom have type 1 diabetes. He testified to FDA representing the Endocrine Society (ES) as part of a successful effort to get direct dosing approval for the Dexcom G5 CGM, and represented ES in a key meeting with CMS that led to approval of CGM coverage for Medicare patients. He also represents ES in a multi-organization group working with CMS to update insulin pump policies. He co-authored multiple chapters in the American Diabetes Association 2013 book, “Putting Your Patients on the Pump”, was primary investigator for 3 published studies on the clinical aspects of CGM use, co-authored a June 2017 Diabetes Technology and Therapeutics review article on CGM use, and several other published commentaries on CGM use. He has presented on CGM and diabetes technology at multiple ADA, EASD and Diabetes Technology Society scientific sessions, and spoken to local, regional, national and international audiences on CGM and insulin pump use
Seating available on a first-come, first-served basis.